Clinical trial
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in…
NCT00195351 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195351 |
|---|---|
| Title | Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection |
| Official title | A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Appendicitis, Cholecystitis, Cross Infection, Diverticulitis, Peritonitis |
| Intervention type | Drug |
| Interventions | tigecycline, ceftriaxone sodium + metronidazole |
| Enrollment | 467 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 25, 2013 |
| Countries | Argentina, Brazil, Canada, Chile, Mexico, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: